Related references
Note: Only part of the references are listed.Hepatitis C Pharmacogenetics: State of the Art in 2010
Nezam H. Afdhal et al.
HEPATOLOGY (2011)
Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection
Megan M. Dring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection
Gregory J. Dore et al.
GASTROENTEROLOGY (2010)
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner
Golo Ahlenstiel et al.
GASTROENTEROLOGY (2010)
Interferon-α-Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection
Kerstin A. Stegmann et al.
GASTROENTEROLOGY (2010)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
Systemic and Intrahepatic Interferon-Gamma-Inducible Protein 10 kDa Predicts the First-Phase Decline in Hepatitis C Virus RNA and Overall Viral Response to Therapy in Chronic Hepatitis C
Galia Askarieh et al.
HEPATOLOGY (2010)
Consistent Beneficial Effects of Killer Cell Immunoglobulin-Like Receptor 2DL3 and Group 1 Human Leukocyte Antigen-C Following Exposure to Hepatitis C Virus
Susanne Knapp et al.
HEPATOLOGY (2010)
Amino Acid Substitution in Hepatitis C Virus Core Region and Genetic Variation Near the Interleukin 28B Gene Predict Viral Response to Telaprevir with Peginterferon and Ribavirin
Norio Akuta et al.
HEPATOLOGY (2010)
IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice
Golo Ahlenstiel et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection
J. R. Vidal-Castineira et al.
JOURNAL OF VIROLOGY (2010)
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y. Kwo et al.
LANCET (2010)
Telaprevir for Previously Treated Chronic HCV Infection.
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
A novel duplex SSP-PCR typing method for KIR gene profiling
E. Ashouri et al.
TISSUE ANTIGENS (2009)
High Incidence of Hepatitis C Virus Reinfection in a Cohort of Injecting Drug Users
Campbell Kynoch Aitken et al.
HEPATOLOGY (2008)
HLA-A, B, Cw, DRB1, DQB1 and DPB1 alleles and haplotypes in the genetically homogenous Irish population
C. Dunne et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2008)
Keeping NK cells in highly regulated antiviral warfare
Seung-Hwan Lee et al.
TRENDS IN IMMUNOLOGY (2007)
IL-28 elicits antitumor responses against murine fibrosarcoma
Muneo Numasaki et al.
JOURNAL OF IMMUNOLOGY (2007)
Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics
Tobias Marcello et al.
GASTROENTEROLOGY (2006)
Antitumor activity of IFN-ℷ in murine tumor models
Atsuko Sato et al.
JOURNAL OF IMMUNOLOGY (2006)
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies
JM Micallef et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
JJ Feld et al.
NATURE (2005)
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
SI Khakoo et al.
SCIENCE (2004)
Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe
CS Witt et al.
TISSUE ANTIGENS (2002)
Molecular diversity of the HLA-C gene identified in a Caucasian population
F Williams et al.
HUMAN IMMUNOLOGY (2002)
Share Paper
